LFB SA Board of Directors
Composition of the LFB SA Board of Directors, chaired by Denis DELVAL, Chairman and CEO of LFB.
Government commissioner:
Grégory EMERY
Deputy Director-General for Health
French government representative:
Jérémie GUE
Head of the Legal Division at the Government Investments Agency (APE)
Members of the Board appointed by the General Assembly, proposed by French State:
Pascale AUGÉ
Chair of the Executive Board, INSERM TRANSFERT SA
Vincent BERJOT
Head of General Economic and Financial Control – Ministry of Economy and Finance
Corinne FAU
Member of the Board and Chief Financial Officer for Enedis
Loïc ROCARD
CEO of TECHNICATOME
Independent members of the Board appointed by the General Assembly:
Gilles BRISSON
Member of the Supervisory Board of Innate Pharma (SA) and of the Supervisory Board of Financière Verdi III (SAS)
Eric DRAPÉ
Executive VP TEVA PHARMACEUTICALS Ltd , Member of the Board Teva Takeda Pharma Ltd (Japan, SAS)
Members of the Board representing employees:
Claire-Marie BERGUES
Production Manager Arras site – LFB BIOMEDICAMENTS
Vincent DENOIS
Director of Infrastructure and IT Operations, Les Ulis - LFB BIOMEDICAMENTS
Marc LASCOMBES
Project engineer, Lille - LFB BIOMEDICAMENTS
Financial and Economic auditors:
François GUILLON
Auditing PRICEWATERHOUSECOOPERS firm
Laurent BRUN
Cabinet CAILLIAU DEDOUIT and associated
Guests
Maurice-Pierre PLANEL
Government auditor, Général Deputy Director of Health
Marc GAZAVE
Economic and Financial Controller